
Running a Sustainable Esketamine Treatment Center for TRD
Led by the moderator, the panelists examine how to build a center that lasts.
Episodes in this series

In the final episode, ‘Running a Sustainable Esketamine Treatment Center for TRD,’ the panelists explored the following critical questions:
What operational considerations matter most to running a sustainable treatment center for treatment-resistant depression?
What has made caring for patients with treatment-resistant depression rewarding, and what lessons would the panelists pass along?
Led by the moderator, the panelists examine how to build a center that lasts. Gene Dolgin emphasizes getting the foundations in place first, including REMS and DEA certification, medical record and practice management systems, and revenue cycle management for in-network care. He explains that Lumin Health chose a one-on-one treatment model and scaled staffing gradually with patient demand. Dr. Yudkoff adds that warmth, privacy, and support for staff are operational priorities in their own right. Both reflect on their partnership and on patients whose lives have changed.
Throughout the conversation, the experts provide a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.
Thank you for watching this Insights series on treatment-resistant depression. Please subscribe to our newsletter for information on upcoming video series.
Related to this article








